NCT03627611View on ClinicalTrials.gov

Identification of Non-responders to Levothyroxine Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

June 22, 2020

Study Completion Date

June 22, 2020

Conditions
HypothyroidismBiomarkersEndocrine System Diseases
Interventions
DRUG

Levothyroxin

3 months

DRUG

Liothyronine

3 months

Trial Locations (1)

Unknown

Oslo University Hospital, Oslo

Sponsors

Collaborators (1)

Hormonlaboratoriet
All Listed Sponsors
collaborator

Hormonlaboratoriet

UNKNOWN

collaborator

Spesialistsenteret Pilestredet Park

UNKNOWN

lead

Oslo University Hospital

OTHER